Chronic Lymphocytic Leukemia Responds to Dermal Chelation

Optimum Health, Natural Healthcare Center50 enrolled

Overview

The purpose of this clinical trial is to identify 50 participants with Chronic Lymphocytic Leukemia (CLL) and follow their total white blood cell (WBC) counts and absolute lymphocyte counts after performing dermal chelation and administering nutritional therapy

The purpose of this clinical trial is to use dermal chelation and hair tissue analysis to identify 50 participants with CLL. The total wbc counts and absolute lymphocyte counts of these participants will be followed after serial dermal chelations and nutritional therapy.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Chronic Lymphocytic Leukemia

Interventions

Dermal ChelationDEVICE

Dermal chelation with Aqua DetoxTM system for one or more hours one or more times each week.

Nutritional TherapyDIETARY_SUPPLEMENT

Vitamins and minerals that will be taken one or more times a day.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of Chronic Lymphocytic Leukemia and has a toxic heavy metal load * Toxic heavy metal load Exclusion Criteria: * Pregnant * Pacemaker implants * Organ transplant recipients * Psychotic episodes or epileptic seizures

Outcomes

Primary Outcomes

Serial Total White Blood Cell Count

Total WBC counts taken on a regular interval.

Time frame: up to 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.